Wednesday, November 4, 2026Updated every morning at 5:30 AM ET
NanotechProgress

Liposomal doxorubicin (Doxil)

Doxil was the first nanomedicine approved in the US, in 1995. It carries the cancer drug doxorubicin inside liposomes, tiny coated fat bubbles that stay in the blood longer and tend to collect in tumors.

Barenholz, Journal of Controlled Release, 2012
Cancer drug carrier · how far it has got4/5Approved or on sale

How far from your life: You can get it now, though it may not be common yet.

Independently sourced

From lab to your life

Why it’s on step 4

  1. 1Lab discovery
  2. 2Working prototype
  3. 3Real-world testing
  4. 4Approved or on sale
  5. 5Everyday life

The rule

A regulator approved or cleared it where approval applies (the FDA, the EMA, a CE mark), or it is sold to the public or to customers beyond a trial.

The short version

What you need to know

Is it really nano?

Truly nano

The drug rides inside nano-sized liposomes; that carrier is what changes where the drug goes in the body.

Barenholz, Journal of Controlled Release, 2012
Where you’ll find it

Used in cancer treatment; a cheaper generic version has been approved in the US since 2013.

HealthDay, 4 Feb 2013
Who’s behind it

First approved in 1995; generic versions since 2013

On the record

Every step, dated

Newest first. Company-reported means the only source so far is the company itself.

  1. Approval

    The FDA approved the first generic version of Doxil, which was on its drug shortage list, to help relieve shortages of the brand-name medicine.

    HealthDay, 4 Feb 2013
  2. Approval

    The FDA approved Doxil, the first nanomedicine approved in the US.

    Barenholz, Journal of Controlled Release, 2012